These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Mounien L, Bizet P, Boutelet I, Gourcerol G, Fournier A, Vaudry H, Jégou S. Neuroscience; 2006 Nov 17; 143(1):155-63. PubMed ID: 16962718 [Abstract] [Full Text] [Related]
11. Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survival. May V, Lutz E, MacKenzie C, Schutz KC, Dozark K, Braas KM. J Biol Chem; 2010 Mar 26; 285(13):9749-9761. PubMed ID: 20093365 [Abstract] [Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptide modulates plasminogen activator expression in rat granulosa cell. Apa R, Lanzone A, Miceli F, Vaccari S, Macchione E, Stefanini M, Canipari R. Biol Reprod; 2002 Mar 26; 66(3):830-5. PubMed ID: 11870092 [Abstract] [Full Text] [Related]
13. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus. Costa L, Santangelo F, Li Volsi G, Ciranna L. Hippocampus; 2009 Jan 26; 19(1):99-109. PubMed ID: 18727050 [Abstract] [Full Text] [Related]
14. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice. Yokai M, Kurihara T, Miyata A. Mol Pain; 2016 Jan 26; 12():. PubMed ID: 27175011 [Abstract] [Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland. Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG. Int J Mol Med; 2002 Mar 26; 9(3):233-43. PubMed ID: 11836629 [Abstract] [Full Text] [Related]
16. In Silico Screening Identified Novel Small-molecule Antagonists of PAC1 Receptor. Takasaki I, Watanabe A, Yokai M, Watanabe Y, Hayakawa D, Nagashima R, Fukuchi M, Okada T, Toyooka N, Miyata A, Gouda H, Kurihara T. J Pharmacol Exp Ther; 2018 Apr 26; 365(1):1-8. PubMed ID: 29363578 [Abstract] [Full Text] [Related]
17. VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells. de Boisvilliers M, Perrin F, Hebache S, Balandre AC, Bensalma S, Garnier A, Vaudry D, Fournier A, Festy F, Muller JM, Chadéneau C. Peptides; 2016 Apr 26; 78():30-41. PubMed ID: 26826611 [Abstract] [Full Text] [Related]
18. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R. Reproduction; 2007 Aug 26; 134(2):281-92. PubMed ID: 17660238 [Abstract] [Full Text] [Related]
19. Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide. Gupte RP, Kadunganattil S, Shepherd AJ, Merrill R, Planer W, Bruchas MR, Strack S, Mohapatra DP. Neuropharmacology; 2016 Feb 26; 101():291-308. PubMed ID: 26456351 [Abstract] [Full Text] [Related]
20. PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF. Ogata K, Shintani N, Hayata-Takano A, Kamo T, Higashi S, Seiriki K, Momosaki H, Vaudry D, Vaudry H, Galas L, Kasai A, Nagayasu K, Nakazawa T, Hashimoto R, Ago Y, Matsuda T, Baba A, Hashimoto H. PLoS One; 2015 Feb 26; 10(3):e0120526. PubMed ID: 25807538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]